Combination therapy with insulin and metformin.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
L S Hermann

Abstract

To review the clinical usefulness of combination therapy with insulin and metformin. Basic considerations about the use of insulin in non-insulin-dependent diabetes mellitus (NIDDM) and the interaction of metformin with insulin are outlined. The clinical documentation of this therapeutic strategy is reviewed, with emphasis on controlled studies. In addition, the use of this drug combination in insulin-dependent diabetes mellitus (IDDM) is briefly addressed. Insulin is used in patients with NIDDM when adequate plasma glucose control can no longer be maintained by orally administered agents. Metformin ameliorates insulin resistance, reduces hyperinsulinemia, and counteracts weight gain. It exerts an insulin-sparing and antihyperglycemic effect and may improve cardiovascular risk factors. Although these effects have been demonstrated consistently in several controlled studies, relatively few patients have been treated with insulin + metformin (with or without sulfonylurea). The combination is well tolerated, commonly used, and approved in several countries. No specific guidelines have been established for selection of patients, but obese patients with NIDDM who are receiving high doses of insulin are likely to benefit. Patients wh...Continue Reading

References

Nov 12, 1992·The New England Journal of Medicine·H Yki-JärvinenP Seppälä
Jun 1, 1992·Diabetes Care·L C Groop
Jun 1, 1992·Diabetes Care·C J Bailey
Jan 1, 1991·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M JanssenI De Leeuw
Jan 3, 1989·Diabetes Research and Clinical Practice·H GinJ Aubertin
Apr 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·K G Alberti, F A Gries
Oct 1, 1985·Metabolism: Clinical and Experimental·H GinJ Aubertin
Aug 31, 1995·The New England Journal of Medicine·M StumvollJ E Gerich
Mar 1, 1994·British Journal of Pharmacology·C J Bailey, K J Mynett
Mar 1, 1994·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·R W Stout
Sep 1, 1995·Diabetes/metabolism Reviews·N Wiernsperger, J R Rapin
Sep 1, 1995·Diabetes/metabolism Reviews·A GolayJ P Assal
Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner
Apr 11, 1996·The New England Journal of Medicine·J P DesprésP J Lupien
Sep 1, 1995·Diabetes Care·D L WingardA Ferrara
Jun 1, 1996·Diabetes Care·K Yamada, K Nonaka
Jun 1, 1996·Diabetes Care·L N Hanuschak

❮ Previous
Next ❯

Citations

Jan 1, 1978·Advances in Enzyme Regulation·W D SedwickJ Laszlo
Feb 26, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·C J Bailey
Jul 6, 2019·Journal of Diabetes and Metabolic Disorders·Gifty M JojoUday Krishna Baruah

❮ Previous
Next ❯

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.